Fidelity Investments
BIOA

Fidelity Investments’s BioAmber Inc. BIOA Stock Holding History

Fidelity Investments’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-875,000
Closed -$429K – 2747
2017
Q3 		$429K Sell
875,000
-485,000
-36% -$579K ﹤0.01% 2497
2017
Q2 		$3.5M Buy
1,360,000
+25,000
+2% +$57.5K ﹤0.01% 2238
2017
Q1 		$3.1M Buy
1,335,000
+210,000
+19% +$798K ﹤0.01% 2261
2016
Q4 		$6.19M Buy
+1,125,000
New +$5.39M ﹤0.01% 2129

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments's BIOA Position: Q4 2017 in Review

Fidelity Investments sold out of BioAmber Inc. (BIOA) in Q4 2017, closing a stake of 875,000 shares — an estimated $429K sold.

Fidelity Investments first reported a position in BIOA in Q4 2016 and held it in 4 quarters. The position peaked at $6.19M in Q4 2016. 26 funds tracked by Wall St. Rank hold BIOA as of Q4 2017.

  • Fidelity Investments reported no remaining BioAmber Inc. position as of Q4 2017 after selling out during the quarter.
  • Fidelity Investments sold 875,000 BioAmber Inc. shares in Q4 2017, an estimated $429K.
  • Fidelity Investments first reported a position in BioAmber Inc. in Q4 2016 and held it in 4 quarters.
  • Fidelity Investments's BioAmber Inc. position peaked at $6.19M in Q4 2016.
  • 26 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2017.

Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.